Douglas D. Burkett

60 year

Consumer Services

Health Technology

Profile

Douglas D.
Burkett served as Chairman, President & Chief Executive Officer at Zila, Inc. from 2002 to 2007.
He also served as President & Chief Executive Officer at Champions Oncology, Inc. in 2009.
Burkett earned a doctorate degree from Arizona State University in 1994 and an undergraduate degree from Missouri Western State College in 1987.

Former positions of Douglas D. Burkett

Companies	Position	End
CHAMPIONS ONCOLOGY, INC.	President	2009-12-30
Zila, Inc. Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use	Chief Executive Officer	2007-06-12

See the detail of Douglas D. Burkett's experience

Training of Douglas D. Burkett

Missouri Western State College	Undergraduate Degree
Arizona State University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Douglas D. Burkett's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
CHAMPIONS ONCOLOGY, INC.	Health Technology

Private companies	1
Zila, Inc. Zila, Inc. Medical SpecialtiesHealth Technology Zila, Inc., headquartered in Scottsdale, Arizona and founded in 1988, is a diagnostic company that offers prevention, detection and treatment of oral cancer and periodontal disease. Zila manufactures and markets ViziLite Plus with TBlue (“ViziLite Plus”), the company’s product for the detection of oral abnormalities that could lead to cancer. ViziLite Plus is a medical device for use in a popilation risking for oral cancer. Zila designs, manufactures and markets products sold directly to dental professionals for periodontal disease, including the Rotadent Professional Powered Brush, the Pro-Select Platinum ultrasonic scaler and oral pharmaceutical products for both in-office and home-care use	Health Technology